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Background
The evidence for the therapy of autoinflammatory dis-
eases is limited. There are few randomized controlled
trials (RCTs) or cohort studies.
Aim
To provide an up to date literature review about the
response to treatment in autoinflammatory diseases.
Methods
A literature search using Medline and Embase was per-
formed regarding the treatment of Blau’s syndrome,
Behçet’s disease, CAPS, CRMO, DIRA, FMF, MKD,
NLRP12-mediated periodic fever, PAPA, PFAPA and
TRAPS.
Results
RCTs provide evidence for rilonacept and canakinumab
in CAPS, colchicine in FMF and (adeno)tonsillectomy in
PFAPA syndrome. For Behçet disease, RCTs have been
conducted on the effect of several drugs, including col-
chicine, azathioprine, cyclosporine A, interferon alfa,
etanercept, sucralfate suspension and pimecrolimus.
Descriptive studies suggest that NSAIDs and corticoster-
oids are highly effective in respectively CRMO and
PFAPA and moderately effective in the other diseases.
Etanercept and anakinra appear to induce a complete or
partial response in most patients with MKD, TRAPS,
PAPA and colchicine-resistant FMF. Anakinra appears
to induce a complete response in the majority of the
CAPS and DIRA patients, but seems to be less effective
in NLRP12-mediated periodic fever. Complete remission
by infliximab is described in cases with Blau’s syndrome,
CRMO, PAPA, refractory FMF and Behçet disease, but
the effect of infliximab in TRAPS patients seems to be
disappointing.
Conclusion
Reported findings were compared to the results of the
Eurofever registry. These combined results could serve
as a base for therapeutic guidelines and identify candi-
date drugs for future therapeutic trials.
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